SpineGuide Technologies

SpineGuide Technologies is a private medical device company focused on scoliosis treatment, particularly in pediatric patients. The company is developing CurvRITE, a proprietary 3D multi-segment growth-guidance rod system intended to correct spinal curvature in a single surgery while allowing continued noninvasive spinal growth. Its technology is positioned as a growth-friendly alternative to repeated surgical lengthening procedures and potentially to final fusion surgery in selected patients. The company has received U.S. FDA Breakthrough Device Designation for CurvRITE in early-onset scoliosis and has also announced designation related to adolescent idiopathic scoliosis. SpineGuide describes itself as a global medical device company with offices in the United States and China and appears to be raising capital to support a pivotal study and FDA premarket submission.